human plasma in which the labile antihemophilic globulin component, present in fresh plasma, has been preserved; it is used to relieve dysfunction of the hemostatic mechanism in hemophilia temporarily.
As scientists who evolve with technology we treat innovation as a way of life, a life we dedicate to improvement and advancement of Safety, Health and Environment.
